Nanobac Pharmaceuticals Incorporated is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Nanobac Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Nanobac Pharmaceuticals Incorporated is worth, separate from its market price. There are two main types of Nanobac Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Nanobac Pharmaceuticals stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Nanobac Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Nanobac Stock trading window is adjusted to America/New York timezone.
Nanobac
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Nanobac Stock Analysis Notes
The company had not issued any dividends in recent years. Nanobac Pharmaceuticals had 1:4 split on the 27th of March 2000. Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles . The company was founded in 1994 and is based in Tampa, Florida. Nanobac Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people. To find out more about Nanobac Pharmaceuticals Incorporated contact John Stanton at 813-865-1125.
Nanobac Pharmaceuticals Quarterly Total Revenue
4,368
Nanobac Pharmaceuticals Investment Alerts
Nanobac Pharmaceuticals generated a negative expected return over the last 90 days
Nanobac Pharmaceuticals has some characteristics of a very speculative penny stock
Nanobac Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 17.62 K. Net Loss for the year was (6.58 M) with profit before overhead, payroll, taxes, and interest of 3.1 K.
Nanobac Pharmaceuticals Incorporated currently holds about 3.93 K in cash with (910.89 K) of positive cash flow from operations.
Nanobac Pharmaceuticals has a very weakfinancial position based on the latest SEC disclosures
Nanobac Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 124.75 K.
Nanobac Pharmaceuticals has return on total asset (ROA) of (0.3684) % which means that it has lost $0.3684 on every $100 spent on assets. This is way below average. Nanobac Pharmaceuticals' management efficiency ratios could be used to measure how well Nanobac Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Nanobac Pharmaceuticals' Return On Capital Employed is relatively stable compared to the past year. As of 03/30/2025, Return On Equity is likely to grow to 2.63, though Return On Tangible Assets are likely to grow to (92.96). As of 03/30/2025, Change To Liabilities is likely to grow to about 632.9 K, while Total Current Liabilities is likely to drop slightly above 4.6 M.
Nanobac Pharmaceuticals' management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Operating Margin
(151.42)
Beta
(38.01)
Return On Assets
(0.37)
Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nanobac Pharmaceuticals, as well as the relationship between them.
Nanobac Pharmaceuticals Price Movement Analysis
The output start index for this execution was six with a total number of output elements of fifty-five. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nanobac Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nanobac Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Nanobac Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Nanobac Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nanobac shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nanobac Pharmaceuticals. By using and applying Nanobac Stock analysis, traders can create a robust methodology for identifying Nanobac entry and exit points for their positions.
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Nanobac Pharmaceuticals to your portfolios without increasing risk or reducing expected return.
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.